Clinical Trials on Advanced Uveal Melanoma in Netherlands
Total 380 results
-
Leiden University Medical CenterRecruiting
-
Radboud University Medical CenterRotterdam Eye HospitalTerminated
-
Novartis PharmaceuticalsCompletedUveal MelanomaUnited Kingdom, France, Netherlands, United States
-
Array Biopharma, now a wholly owned subsidiary...TerminatedUveal MelanomaUnited States, France, Germany, Netherlands, Spain, United Kingdom
-
Novartis PharmaceuticalsTerminatedUveal MelanomaUnited States, Australia, France, Netherlands, Spain, Norway
-
Foghorn Therapeutics Inc.TerminatedMetastatic Uveal MelanomaUnited States, Netherlands, France
-
Novartis PharmaceuticalsRecruitingMetastatic Uveal MelanomaUnited States, Australia, France, Netherlands, Switzerland, Germany, Spain
-
Leiden University Medical CenterRecruitingUveal MelanomaNetherlands
-
Erasmus Medical CenterLudwig Institute for Cancer Research; Dutch Cancer Society; Stichting Coolsingel... and other collaboratorsRecruitingMelanoma | Head and Neck Cancer | Melanoma, UvealNetherlands
-
AstraZenecaCompletedUveal Melanoma | MetastaticUnited States, Czech Republic, Spain, United Kingdom, Germany, Canada, Israel, Netherlands, Belgium, France, Finland
-
IDEAYA BiosciencesRecruitingMetastatic Uveal MelanomaUnited States, Canada, Israel, Spain, Australia, Germany, France, Italy, United Kingdom, Netherlands, Belgium, Poland, Switzerland
-
Azienda Ospedaliera di PerugiaNot yet recruitingAdvanced Melanoma | Early MelanomaItaly, Sweden, France, Germany, Netherlands, Poland, Spain
-
Immunocore LtdActive, not recruitingUveal MelanomaUnited States, Canada, United Kingdom, Spain, France, Germany, Poland, Australia, Belgium, Italy, Netherlands, Russian Federation, Switzerland, Ukraine
-
PfizerCompletedLocally Advanced or Metastatic NRAS Mutant MelanomaUnited States, Australia, Germany, Italy, Netherlands
-
IDEAYA BiosciencesRecruitingUveal MelanomaUnited States, Australia, Canada, Netherlands, Italy, France, Germany, United Kingdom
-
Array BioPharmaTerminatedLocally Advanced Metastatic BRAF Mutant MelanomaAustralia, Canada, Netherlands, United States
-
The Netherlands Cancer InstituteRecruiting
-
Bristol-Myers SquibbCompletedMetastatic Melanoma | Advanced MelanomaUnited States, Netherlands, Spain
-
PfizerPierre Fabre LaboratoriesActive, not recruitingAdvanced Solid Tumors | Metastatic MelanomaUnited States, Spain, Belgium, Canada, Netherlands
-
The Netherlands Cancer InstituteAmgenActive, not recruitingMelanoma Stage IV | Melanoma Stage IIINetherlands
-
The Netherlands Cancer InstituteUnknownStage IV Skin Melanoma | Eye; MelanomaNetherlands
-
A.J.M. van den EertweghIdera Pharmaceuticals, Inc.Recruiting
-
The Netherlands Cancer InstituteMerck Sharp & Dohme LLCUnknownMetastatic MelanomaNetherlands
-
The Netherlands Cancer Institute4SCActive, not recruiting
-
University of TwenteNot yet recruitingMelanoma (Skin)Netherlands
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingStage III Skin MelanomaNetherlands
-
University Medical Center GroningenUnknownMelanoma (Skin)Netherlands
-
The Netherlands Cancer InstituteCopenhagen University Hospital at HerlevActive, not recruitingMetastatic MelanomaNetherlands, Denmark
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and Development; Dutch...Active, not recruiting
-
Hoffmann-La RocheTerminatedAdvanced BRAFV600 Wild-type MelanomaUnited States, Korea, Republic of, Australia, Belgium, France, Russian Federation, Italy, Netherlands, Spain, United Kingdom, Brazil, Poland, Germany, Greece, Hungary
-
Radboud University Medical CenterDutch Cancer SocietyCompletedMelanoma Stage III or IVNetherlands
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingMalignant Melanoma Stage IIIAustria, Netherlands, Australia, Sweden
-
Erasmus Medical CenterRecruitingImmunotherapy | Melanoma Stage IV | Melanoma Stage III | Toxicity, DrugNetherlands
-
Radboud University Medical CenterDutch Cancer SocietyCompletedMelanoma Stage III or IVNetherlands
-
Leiden University Medical CenterPierre Fabre LaboratoriesRecruitingMelanoma Stage III | In-Transit Metastasis of Cutaneous MelanomaNetherlands
-
AstraZenecaCompletedMelanoma | Malignant MelanomaUnited Kingdom, Netherlands
-
Netherlands Working Group on Immunotherapy of OncologyHoffmann-La Roche; Amsterdam UMC, location VUmc; The Netherlands Cancer InstituteTerminated
-
BioNTech US Inc.RecruitingMetastatic Melanoma | Unresectable MelanomaBelgium, Netherlands, Spain
-
Radboud University Medical CenterCompleted
-
Radboud University Medical CenterCompleted
-
Zuyderland Medisch CentrumRecruiting
-
Zuyderland Medisch CentrumCompleted
-
Radboud University Medical CenterCompleted
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsBelgium, Spain, Germany, Netherlands, Finland
-
The Netherlands Cancer InstituteUniversity of Pavia; Academisch Medisch Centrum - Universiteit van Amsterdam... and other collaboratorsRecruiting
-
Amsterdam UMC, location VUmcBristol-Myers SquibbRecruiting
-
Radboud University Medical CenterCompleted
-
Radboud University Medical CenterCompleted
-
Bristol-Myers SquibbCompleted
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsSpain, New Zealand, Hungary, Serbia, Germany, Portugal, Netherlands, Greece, Australia